These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 8056702)
1. Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies. D'Antonio D; Piccolomini R; Iacone A; Fioritoni G; Parruti G; Betti S; Quaglietta AM; Accorsi P; Dell'Isola M; Favalli C J Antimicrob Chemother; 1994 Apr; 33(4):837-44. PubMed ID: 8056702 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis. Dellamonica P; Bernard E; Etesse H; Garraffo R; Drugeon HB Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1024-30. PubMed ID: 2515961 [TBL] [Abstract][Full Text] [Related]
3. [Comparative efficacy and safety of ciprofloxacin, ofloxacin, and pefloxacin in treatment of respiratory infections in children with cystic fibrosis]. Postnikov SS Antibiot Khimioter; 2001; 46(3):16-20. PubMed ID: 11548276 [TBL] [Abstract][Full Text] [Related]
4. Comparison of norfloxacin and pefloxacin in the prophylaxis of bacterial infection in neutropenic cancer patients. D'Antonio D; Iacone A; Fioritoni G; Betti S; Dell'Isola M; Quaglietta AM; Accorsi P; Pantalone V; Recchia A; Piergallini A Drugs Exp Clin Res; 1992; 18(4):141-6. PubMed ID: 1451644 [TBL] [Abstract][Full Text] [Related]
5. [Activity of fluoroquinolones studied on a model of suppurative meningoencephalitis caused by Pseudomonas aeruginosa in mice]. Padeĭskaia EN; Mnatsakanian VE Antibiot Khimioter; 1991 Jul; 36(7):25-8. PubMed ID: 1953184 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of amikacin, ofloxacin, pefloxacin, ciprofloxacin, enoxacin and fleroxacin in experimental left-sided Pseudomonas aeruginosa endocarditis. Papadakis JA; Samonis G; Maraki S; Boutsikakis J; Petrocheilou V; Saroglou G Chemotherapy; 2000; 46(2):116-21. PubMed ID: 10671762 [TBL] [Abstract][Full Text] [Related]
7. Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy. Liang RH; Yung RW; Chan TK; Chau PY; Lam WK; So SY; Todd D Antimicrob Agents Chemother; 1990 Feb; 34(2):215-8. PubMed ID: 2327768 [TBL] [Abstract][Full Text] [Related]
8. Prevention of infections in neutropenic patients with pefloxacin. Meunier F J Antimicrob Chemother; 1990 Oct; 26 Suppl B():69-73. PubMed ID: 2258354 [TBL] [Abstract][Full Text] [Related]
9. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Ann Intern Med; 1991 Jul; 115(1):7-12. PubMed ID: 2048868 [TBL] [Abstract][Full Text] [Related]
10. Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: effect of augmented gram-positive activity on infectious morbidity. National Cancer Institute of Canada Clinical Trials Group. Bow EJ; Mandell LA; Louie TJ; Feld R; Palmer M; Zee B; Pater J Ann Intern Med; 1996 Aug; 125(3):183-90. PubMed ID: 8686975 [TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics of ciprofloxacin, ofloxacin and pefloxacin in human aqueous humour. Giamarellou H; Kanellas D; Kavouklis E; Petrikkos G; Gabriel L Eur J Clin Microbiol Infect Dis; 1993 Apr; 12(4):293-7. PubMed ID: 8513819 [TBL] [Abstract][Full Text] [Related]
12. [The in vitro activity of ofloxacin, pefloxacin and ciprofloxacin against various gram negative bacteria isolated from urinary tract infections]. Tunçkanat F; Yuluğ N Mikrobiyol Bul; 1988; 22(3):187-92. PubMed ID: 3252111 [TBL] [Abstract][Full Text] [Related]
13. Concentration of pefloxacin in feces during infection prophylaxis in neutropenic patients. van de Leur JJ; Vollaard EJ; Janssen AJ; Dofferhoff AS Antimicrob Agents Chemother; 1995 May; 39(5):1182-4. PubMed ID: 7625811 [TBL] [Abstract][Full Text] [Related]
14. Infection prophylaxis in neutropenic patients with acute leukaemia--a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole/colistin. Arning M; Wolf HH; Aul C; Heyll A; Scharf RE; Scheider W J Antimicrob Chemother; 1990 Nov; 26 Suppl D():137-42. PubMed ID: 2286588 [TBL] [Abstract][Full Text] [Related]
15. Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli. Gomez L; Garau J; Estrada C; Marquez M; Dalmau D; Xercavins M; Martí JM; Estany C Cancer; 2003 Jan; 97(2):419-24. PubMed ID: 12518366 [TBL] [Abstract][Full Text] [Related]
16. The role of quinolones in staphylococcal infection. Shah PM J Chemother; 1989 Aug; 1(4):253-6. PubMed ID: 2809692 [TBL] [Abstract][Full Text] [Related]
17. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia]. Qin TJ; Mi YC; Feng SZ; Li DP; Wei JL; Yang DL; Han MZ; Wang JX; Bian SG Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1389-93. PubMed ID: 17785058 [TBL] [Abstract][Full Text] [Related]
18. Quinolone therapy of Klebsiella pneumoniae sepsis following irradiation: comparison of pefloxacin, ciprofloxacin, and ofloxacin. Brook I; Elliott TB; Ledney GD Radiat Res; 1990 May; 122(2):215-7. PubMed ID: 2186431 [TBL] [Abstract][Full Text] [Related]
19. Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patients. Smith GM; Leyland MJ; Farrell ID; Geddes AM J Antimicrob Chemother; 1986 Nov; 18 Suppl D():165-74. PubMed ID: 3468101 [TBL] [Abstract][Full Text] [Related]
20. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies. Reuter S; Kern WV; Sigge A; Döhner H; Marre R; Kern P; von Baum H Clin Infect Dis; 2005 Apr; 40(8):1087-93. PubMed ID: 15791505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]